{"id":"https://openalex.org/W24911520","doi":null,"title":"[Cumulative survival rate of chemotherapy with CDDP for malignant ovarian tumors].","display_name":"[Cumulative survival rate of chemotherapy with CDDP for malignant ovarian tumors].","publication_year":1990,"publication_date":"1990-04-01","ids":{"openalex":"https://openalex.org/W24911520","mag":"24911520","pmid":"https://pubmed.ncbi.nlm.nih.gov/2358717"},"language":"ja","primary_location":{"id":"pmid:2358717","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2358717","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon Sanka Fujinka Gakkai zasshi","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M Takada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Takada","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N Usui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Usui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002997737","display_name":"Kimihide Yoshida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Yoshida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"H Hirayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Hirayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Suzuki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030479285","display_name":"Hitoshi TAKEUCHI","orcid":"https://orcid.org/0000-0002-4255-623X","observed_orcids":["https://orcid.org/0000-0002-4255-623X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Takeuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049226902","display_name":"Hiromi Wada","orcid":"https://orcid.org/0000-0001-6171-1963","observed_orcids":["https://orcid.org/0000-0001-6171-1963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Wada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T Iwasa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Iwasa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025547089","display_name":"Tatsuo Yamamoto","orcid":"https://orcid.org/0000-0001-5147-3711","observed_orcids":["https://orcid.org/0000-0001-5147-3711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Yamamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"I Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Nagasawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2461,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.567197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"4","first_page":"333","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9190000295639038},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.44600000977516174},{"id":"https://openalex.org/keywords/cumulative-survival-rate","display_name":"cumulative survival rate","score":0.7110000252723694},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6349999904632568},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.7480000257492065},{"id":"https://openalex.org/keywords/intraperitoneal-cisplatin","display_name":"intraperitoneal cisplatin","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.8092837333679199},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.5918142199516296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5876531004905701},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5664412975311279},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5583885908126831},{"id":"https://openalex.org/C2780678043","wikidata":"https://www.wikidata.org/wiki/Q743241","display_name":"Group A","level":2,"score":0.5214604735374451},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.4892689883708954},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4370478689670563},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43691202998161316},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42765673995018005},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41865769028663635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11405715346336365},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06588298082351685},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008937","descriptor_name":"Mitomycins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2358717","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2358717","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon Sanka Fujinka Gakkai zasshi","raw_type":"Comparative Study"},{"id":"mag:24911520","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2358717","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W2070435400","https://openalex.org/W2149790590","https://openalex.org/W2021411636","https://openalex.org/W2169574492","https://openalex.org/W2017635145","https://openalex.org/W2093878836","https://openalex.org/W1984947474","https://openalex.org/W1995151196","https://openalex.org/W2027458529","https://openalex.org/W2141363952","https://openalex.org/W2139950666","https://openalex.org/W2134945818","https://openalex.org/W2054472394","https://openalex.org/W2098047948","https://openalex.org/W1969589052","https://openalex.org/W2093705034","https://openalex.org/W1923917571","https://openalex.org/W2031813438","https://openalex.org/W2039878276","https://openalex.org/W2097566341","https://openalex.org/W2076411929","https://openalex.org/W2008430756","https://openalex.org/W2066776411","https://openalex.org/W2003933970","https://openalex.org/W2105055793","https://openalex.org/W2118764913","https://openalex.org/W1993290612","https://openalex.org/W2088576398","https://openalex.org/W2036918577","https://openalex.org/W2057635936","https://openalex.org/W1992750250","https://openalex.org/W6712090404","https://openalex.org/W2099826413","https://openalex.org/W2133519004","https://openalex.org/W1968069093","https://openalex.org/W1986584261","https://openalex.org/W2114570899","https://openalex.org/W2166769366","https://openalex.org/W2077563248","https://openalex.org/W2087079041","https://openalex.org/W2069096810","https://openalex.org/W2095029191","https://openalex.org/W2137111577","https://openalex.org/W2030165656","https://openalex.org/W1985231736","https://openalex.org/W1601457926","https://openalex.org/W2113945572","https://openalex.org/W2132086450"],"related_works":["https://openalex.org/W15143329","https://openalex.org/W1557926013","https://openalex.org/W2414840210","https://openalex.org/W2358640949","https://openalex.org/W2398872186","https://openalex.org/W2413018358","https://openalex.org/W2039223647","https://openalex.org/W1973153496","https://openalex.org/W2078667728","https://openalex.org/W2095545458"],"abstract_inverted_index":{"The":[0,21,44],"current":[1],"study":[2],"covered":[3],"159":[4],"patients":[5],"with":[6,203],"primary":[7],"malignant":[8],"ovarian":[9],"carcinoma":[10],"who":[11],"underwent":[12],"various":[13],"kinds":[14],"of":[15,75,78,86,89],"chemotherapy":[16],"between":[17],"1977":[18],"and":[19,36,56,98,115,129,135,144,187],"1987.":[20],"cases":[22],"in":[23,110,119,198],"each":[24],"stage":[25,45],"were":[26,133],"first":[27],"divided":[28,50],"into":[29,51,68],"two":[30,206],"groups.":[31],"Group":[32,37,47,65,111,120,138,147],"A":[33,53,70,112,139,158,177,200],"(CDDP":[34],"Group)":[35,55],"B":[38,58,81,121,186],"(non-CDDP":[39,101],"Group),":[40,97],"for":[41,137,146,156,165,175,184,189],"comparative":[42],"analysis.":[43],"I":[46],"was":[48,66,113,122,159,178],"further":[49],"Subgroup":[52,57,69,80,94,99,157,166,176,185,190,199],"(CAP":[54],"(FAM":[59,96],"Group).":[60,102],"Similarly,":[61],"the":[62,106,116,127,152,171,204],"Stage":[63,104,125,150,169],"III":[64],"subdivided":[67],"(three":[71,82],"or":[72,83],"more":[73,84],"courses":[74,85],"ip":[76],"administration":[77,88],"CDDP).":[79],"iv":[87],"CDDP":[90],"centering":[91],"on":[92],"CAP),":[93],"C":[95],"D":[100],"In":[103,124,149,168],"I,":[105],"five-year":[107,130,153],"survival":[108,131,154,173],"rate":[109,155,174],"94%":[114],"comparable":[117],"figure":[118],"59%.":[123],"III,":[126,170],"two-year":[128,172],"rates":[132],"31%":[134],"11%":[136],"as":[140,161,180,201],"opposed":[141],"to":[142,163,182],"24%":[143],"18%":[145],"B.":[148,167],"Ia,":[151],"90%":[160],"compared":[162,181,202],"75%":[164],"67%":[179],"28%":[183],"30%":[188],"C.":[191],"This":[192],"indicated":[193],"a":[194],"very":[195],"good":[196],"prognosis":[197],"other":[205],"subgroups.":[207]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}